1. Volume 145, Issue 4, Pages 766-774.e1 (October 2013)
Early Azathioprine Therapy Is No More Effective Than Placebo for Newly Diagnosed Crohn's Disease 
Julián Panés, Antonio López–SanRomán, Fernando Bermejo, Valle García–Sánchez, Maria Esteve, Yolanda Torres, Eugeni Domènech, Marta Piqueras, María Gomez–García, Ana Gutiérrez, Carlos Taxonera, Miquel Sans 
Gastroenterology 
Volume 145, Issue 4, Pages e1 (October 2013)
DOI: /j.gastro
Copyright © 2013 AGA Institute Terms and Conditions

2. Figure 1
Actuarial probability of survival free of relapse defined as a CDAI score >175 in patients treated with azathioprine and placebo.
Gastroenterology  , e1DOI: ( /j.gastro )
Copyright © 2013 AGA Institute Terms and Conditions

3. Figure 2
Mean (A) CDAI and (B) IBDQ scores throughout the study in the groups treated with azathioprine (closed symbols) and placebo (open symbols). SDs of the mean are represented for each value.
Gastroenterology  , e1DOI: ( /j.gastro )
Copyright © 2013 AGA Institute Terms and Conditions

4. Supplementary Figure 1 Enrollment and outcomes through week 76.
Gastroenterology  , e1DOI: ( /j.gastro )
Copyright © 2013 AGA Institute Terms and Conditions